bluebird bio | 4:持股變動聲明-高管 Sterling O. James
bluebird bio | 4:持股變動聲明-董事 Cloonan Michael
bluebird bio | 3:首次持股聲明-董事 Cloonan Michael
bluebird bio | 3:首次持股聲明-高管 Sterling O. James
bluebird bio | 4:持股變動聲明-高管 Klima Thomas J
bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(1.80%)
bluebird bio | 4:持股變動聲明-高管 Obenshain Andrew
bluebird bio | 4:持股變動聲明-高管 Vittiglio Joseph
bluebird bio | 4:持股變動聲明-高管 Colvin Richard A
bluebird bio | 4:持股變動聲明-高管 Krawtschuk Christopher
bluebird bio | 4:持股變動聲明-高管 Klima Thomas J
bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-PFM Health Sciences, LP(1.9%),PFM Health Sciences GP, LLC(1.9%)等
bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.9%),Tang Capital Management, LLC(0.9%)等
bluebird bio | SC 13G:超過5%持股股東披露文件-Alyeska Investment Group, L.P.(6.32%),Alyeska Fund GP, LLC(6.32%)等
bluebird bio | SC 13G:超過5%持股股東披露文件-Granahan Investment Management LLC(7.38%)
bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.61%)
bluebird bio | SC 13G:超過5%持股股東披露文件-THE GOLDMAN SACHS GROUP, INC.(6.4 %),GOLDMAN SACHS & CO. LLC(6.4 %)
bluebird bio | 4:持股變動聲明-高管 Klima Thomas J
bluebird bio | 4:持股變動聲明-高管 Vittiglio Joseph
bluebird bio | 4:持股變動聲明-高管 Obenshain Andrew
暫無數據